Cleveland-based KeyCorp and First Niagara Financial Group Inc will sell 18 First Niagara branches in and around Buffalo, New York, to resolve antitrust concerns tied to KeyCorp’s planned acquisition of First Niagara, the U.S. Justice Department said on Thursday.
The department said the 18 branches have approximately $1.7 billion in deposits.
The deal was valued at $4.1 billion when it was announced in October. It is the latest in a string of mergers among smaller U.S. banks, spurred by years of near-zero interest rates and higher costs related to stricter regulations imposed since the financial crisis.
In an unusual request by a governor, New York’s Andrew Cuomo urged federal regulators in February to block the acquisition, saying a merger would impede retail banking competition and cost thousands of jobs upstate.
He said it would add to the tens of thousands of Buffalo-area residents who have difficulty accessing bank branches, and likely force many people to rely on costly alternatives such as payday lenders and check-cashing providers.
The deal is subject to further regulatory approvals, the Justice Department said.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas